Physician profile
Dana Brown
NPI 1700221264
$500.95
in general payments reported to CMS, 2019-2025
8 companies · $91.71 in 2025
The $91.71 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $158 · 2022: $69.31 · 2023: $22.95 · 2024: $15.38 · 2025: $91.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $159.17 | 2019-2020 | |
| Boston Scientific Corporation | $106.76 | 2020 | |
| Sanofi Pasteur INC. | $73.72 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $70.92 | 2019-2024 | Gardasil 9, Vaxelis, Gardasil |
| Ars Pharmaceuticals Operations, INC. | $25.28 | 2025 | Neffy |
| Cranial Technologies, INC | $22.72 | 2020 | |
| Cipher Pharmaceuticals US LLC | $21.23 | 2025 | Spinosad, Natroba |
| Krystal Biotech INC | $21.15 | 2025 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.